Xu Yumei, Shao Zhiying, Tang Tianyou, Liu Guihong, Yao Yuanhu, Wang Jianshe, Zhang Longzhen
Department of Radiation Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221006, P.R. China.
Clinical College of Xuzhou Medical University, Xuzhou, Jiangsu 221006, P.R. China.
Oncol Lett. 2018 Nov;16(5):6126-6132. doi: 10.3892/ol.2018.9332. Epub 2018 Aug 20.
The objective of the present study was to investigate the association between thyroid gland-dosimetric parameters and hypothyroidism induced by intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma (NPC). A total of 52 patients with NPC treated in the Department of Radiation Oncology of The Affiliated Hospital of Xuzhou Medical University, from May 2008 to December 2016 were retrospectively enrolled in the present study and divided into two groups based on thyroid function: The euthyroid and hypothyroid groups. The association between hypothyroidism and clinical or dosimetric parameters were analyzed. Females had a significantly increased probability of suffering from radiation-induced hypothyroidism (RIHT), compared with males (P=0.010). The occurrence of RIHT was significantly negatively associated with thyroid volume prior to radiotherapy (P=0.048). Furthermore, the mean dose (Dmean) and V50 in the hypothyroidism group were significantly increased, compared with the euthyroidism group (P=0.017 and P=0.023, respectively). During the treatment optimization period, dose constraints associated with the thyroid gland demonstrated a significantly protective effect on thyroid function compared with the unconstrained group (P=0.034). According to the receiver operating characteristic curves, the threshold value was 5,160 cGy for Dmean and 54.5% for V50. The 3-year cumulative incidence of RIHT was 67.8% when the Dmean value was >5,160 cGy and 44.6% when the Dmean was <5,160 cGy (log rank test, P=0.036). Furthermore, the 3-year cumulative incidence was 66.1% when the V50 was >54.5%, and 29.9% when the V50 was <54.5% (log rank test, P=0.025). In conclusion, RIHT is associated with radiation dose, particularly with Dmean and V50 of the thyroid gland. Dose constraints associated with the thyroid gland significantly reduced the incidence of hypothyroidism compared with the unconstrained group.
本研究的目的是探讨鼻咽癌(NPC)患者调强放疗所致甲状腺剂量学参数与甲状腺功能减退之间的关联。回顾性纳入2008年5月至2016年12月在徐州医科大学附属医院放射肿瘤学科室接受治疗的52例NPC患者,并根据甲状腺功能将其分为两组:甲状腺功能正常组和甲状腺功能减退组。分析甲状腺功能减退与临床或剂量学参数之间的关联。与男性相比,女性发生放射性甲状腺功能减退(RIHT)的概率显著增加(P = 0.010)。RIHT的发生与放疗前甲状腺体积显著负相关(P = 0.048)。此外,与甲状腺功能正常组相比,甲状腺功能减退组的平均剂量(Dmean)和V50显著增加(分别为P = 0.017和P = 0.023)。在治疗优化期间,与未设限组相比,甲状腺相关剂量限制对甲状腺功能具有显著的保护作用(P = 0.034)。根据受试者工作特征曲线,Dmean的阈值为5160 cGy,V50的阈值为54.5%。当Dmean值>5160 cGy时,RIHT的3年累积发生率为67.8%;当Dmean<5160 cGy时,3年累积发生率为44.6%(对数秩检验,P = 0.036)。此外,当V50>54.5%时,3年累积发生率为66.1%;当V50<54.5%时,3年累积发生率为29.9%(对数秩检验,P = 0.025)。总之,RIHT与放射剂量相关,尤其是与甲状腺的Dmean和V50相关。与未设限组相比,甲状腺相关剂量限制显著降低了甲状腺功能减退的发生率。